[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Argatroban Market Survey and Trend Research 2018

December 2017 | 86 pages | ID: G3AC330E357EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Pfizer, SANDOZ, GlaxoSmithKline, fresenius-kabi, Mitsubishi Tanabe Pharma, Mitsubishi Tanabe Pharma, Teva Pharmaceutical Industries, WEST-WARD etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Argatroban Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 ARGATROBAN MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Pfizer (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 SANDOZ (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 GlaxoSmithKline (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 fresenius-kabi (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Mitsubishi Tanabe Pharma (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Mitsubishi Tanabe Pharma (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Teva Pharmaceutical Industries (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 WEST-WARD (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

Table Global Argatroban Market 2012-2017, by Type, in USD Million
Table Global Argatroban Market 2012-2017, by Type, in Volume
Table Global Argatroban Market Forecast 2018-2023, by Type, in USD Million
Table Global Argatroban Market Forecast 2018-2023, by Type, in Volume
Table Pfizer Overview List
Table Argatroban Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SANDOZ Overview List
Table Argatroban Business Operation of SANDOZ (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Argatroban Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table fresenius-kabi Overview List
Table Argatroban Business Operation of fresenius-kabi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mitsubishi Tanabe Pharma Overview List
Table Argatroban Business Operation of Mitsubishi Tanabe Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mitsubishi Tanabe Pharma Overview List
Table Argatroban Business Operation of Mitsubishi Tanabe Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Overview List
Table Argatroban Business Operation of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table WEST-WARD Overview List
Table Argatroban Business Operation of WEST-WARD (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Argatroban Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Argatroban Sales Revenue Share, by Companies, in USD Million
Table Global Argatroban Sales Volume 2012-2017, by Companies, in Volume
Table Global Argatroban Sales Revenue Share, by Companies in 2017, in Volume
Table Argatroban Demand 2012-2017, by Application, in USD Million
Table Argatroban Demand 2012-2017, by Application, in Volume
Table Argatroban Demand Forecast 2018-2023, by Application, in USD Million
Table Argatroban Demand Forecast 2018-2023, by Application, in Volume
Table Global Argatroban Market 2012-2017, by Region, in USD Million
Table Global Argatroban Market 2012-2017, by Region, in Volume
Table Argatroban Market Forecast 2018-2023, by Region, in USD Million
Table Argatroban Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure Argatroban Industry Chain Structure
Figure Global Argatroban Market Growth 2012-2017, by Type, in USD Million
Figure Global Argatroban Market Growth 2012-2017, by Type, in Volume
Figure Global Argatroban Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Argatroban Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications